financetom
Business
financetom
/
Business
/
DuPont's Breakup Plan Holds Logic Amid Disadvantages, BofA Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
DuPont's Breakup Plan Holds Logic Amid Disadvantages, BofA Says
May 28, 2024 11:17 AM

01:47 PM EDT, 05/28/2024 (MT Newswires) -- DuPont de Nemours' ( DD ) plan to split up holds clear logic in capturing higher valuations for its Water and Electronics businesses while also showing some disadvantages from smaller market values, BofA Securities said in a note.

Last week, DuPont ( DD ) said it would split into three publicly traded companies, proposing separations of its Electronics and Water businesses in a tax-free manner to shareholders with New DuPont continuing as a diversified industrial company.

Investor interest has been moderate due to the uncertain magnitude of per- and polyfluoroalkyl substances liabilities and the diversity of businesses constraining valuation to well below specialty chemical peers, the report said.

"If a deal were to happen on the announced terms, the breakup would create pure-plays in two end markets with significant long-term growth potential, driven by water shortages and societal electrification, and which we believe could trade at higher

multiples," BofA said.

The report also pointed to challenges to sum-of-the-parts valuation, including a greater PFAS liability risk to the smaller entities, and possible lower multiple for industrial and water businesses against peers.

"While the company's plan to split into 3 companies could create potential upside in our view it will still create 3 smaller

companies that still have PFAS liabilities," the report said.

BofA reiterated its underperform rating on DuPont ( DD ) while raising its price objective to $80 from $74.

Price: 82.19, Change: +1.07, Percent Change: +1.32

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
GSK wins latest trial over Zantac cancer claims
GSK wins latest trial over Zantac cancer claims
Aug 5, 2024
Aug 5 (Reuters) - GSK won the latest trial over claims that discontinued heartburn drug Zantac caused cancer, as a jury on Monday found that the drug was not responsible for an Illinois woman's illness, a company spokesperson said. Carrie Joiner had alleged in her lawsuit in state court in Chicago that she developed colorectal cancer from a carcinogenic contaminant...
--Teradata Expects Cash Expenditure From Severance Payments of About $45 Million-$50 Million
--Teradata Expects Cash Expenditure From Severance Payments of About $45 Million-$50 Million
Aug 5, 2024
05:43 PM EDT, 08/05/2024 (MT Newswires) -- Price: 27.49, Change: -1.66, Percent Change: -5.69 ...
Realty Income beats second-quarter FFO estimates on higher rental revenue
Realty Income beats second-quarter FFO estimates on higher rental revenue
Aug 5, 2024
Aug 5 (Reuters) - Realty Income ( O ) edged past Wall Street expectations for second-quarter funds from operations (FFO) on Monday, as the real estate investment trust benefited from higher rental revenue at its properties. The REIT, which has more than 13,400 properties across the United States and Europe, leases its locations to clients across industries such as retail,...
Atlas Energy Solutions Q2 Net Income Falls, Sales Rise
Atlas Energy Solutions Q2 Net Income Falls, Sales Rise
Aug 5, 2024
05:45 PM EDT, 08/05/2024 (MT Newswires) -- Atlas Energy Solutions ( AESI ) reported Q2 net income late Monday of $0.13 per diluted share, down from $0.67 a year earlier. Analysts polled by Capital IQ expected $0.30. Sales for the quarter ended June 30 rose to $287.5 million from $161.8 million a year earlier. Analysts surveyed by Capital IQ expected...
Copyright 2023-2026 - www.financetom.com All Rights Reserved